Allegiant Private Advisors’s Novartis NVS Stock Holding History

Allegiant Private Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$7M	Sell	76,675 -5,511	-7%	-$491K	1.13%	25
2021 Q1	$7.03M	Sell	82,186 -2,181	-3%	-$196K	1.28%	17
2020 Q4	$7.97M	Buy	+84,367	New	+$7.37M	1.65%	12

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Allegiant Private Advisors's NVS Position: Q2 2021 in Review

Allegiant Private Advisors reduced its Novartis (NVS) stake by 6.7% in Q2 2021, selling an estimated $491K and leaving 76,675 shares worth $7M. The position accounts for 1.13% of the portfolio, ranked #25.

Allegiant Private Advisors first reported a position in NVS in Q4 2020 and has held it in 3 quarters since. The position peaked at $7.97M in Q4 2020. 1,119 funds tracked by Wall St. Rank hold NVS as of Q2 2021.

Allegiant Private Advisors held 76,675 shares of Novartis worth $7M as of Q2 2021.
Allegiant Private Advisors sold 5,511 Novartis shares in Q2 2021, an estimated $491K.
Novartis made up 1.13% of Allegiant Private Advisors's portfolio in Q2 2021, its #25 holding.
Allegiant Private Advisors first reported a position in Novartis in Q4 2020 and has held it in 3 quarters since.
Allegiant Private Advisors's Novartis position peaked at $7.97M in Q4 2020.
1,119 funds tracked by Wall St. Rank held Novartis as of Q2 2021.

Based on Allegiant Private Advisors's 13F filing for Q2 2021, filed 7 Jul 2021.